Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Suku Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Kreditur Perdagangan
Keuangan
Harga Saham
USD
Aktiva
USD 12B
Kas Dan Setara
USD 860.32M
Biaya Penjualan
USD 323.46M
Aset Lancar
USD 2.13B
Kewajiban Lancar
USD 1.24B
UTANG
USD 3.4B
Dividen - Hasil
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
Karyawan
11K
Eps Laba Per Saham
USD 1.06
Modal Dan Cadangan
USD 7.25B
Laba Kotor Pada Penjualan
USD 387.66M
Beban Bunga Utang
USD 24.72M
Pendapatan Bunga
USD 5.75M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 12.57B
Batas Pemasukan
USD 40.72M
Biaya Operasional
USD 628.35M
Laba Operasional
USD 82.77M
Modal Saham Biasa
USD 111.8M
Pe Harga Untuk Laba
30.79
Laba Sebelum Pajak
USD 91.56M
Pendapatan Penjualan
USD 711M
Beban Penjualan Dan Administrasi
USD 253.88M
Saham
USD 387.51M
Kreditur Perdagangan
USD 169.68M
Debitur Perdagangan
USD 691.38M
Kreditur Perdagangan
Perubahan
Tanggal
Agilent
USD 615M
13M
2026-03
Align Technology
USD 123.72M
2.27M
2026-03
Bio Techne
USD 95.6M
3.97M
2026-03
Bio-Rad Laboratories
USD 133.1M
4.1M
2026-03
Bruker
USD 269.1M
53.2M
2026-03
Celltrion
KRW 78.68B
25.51B
2025-12
Charles River Laboratories
USD 133.95M
14.85M
2026-03
Cspc Pharmaceutical
CNY 2.32B
236.83M
2025-12
Danaher
USD 1.79B
54M
2026-03
Dentsply International
USD 259M
41M
2026-03
Deva Holding AS
TRY 809.81M
105.88M
2023-09
Dianthus Therapeutics
USD 5.27M
4.45M
2026-03
Divis Laboratories Ltd
INR 12.11B
1.71B
2026-03
Edwards Lifesciences
USD 181.1M
46.4M
2026-03
Illumina
USD 218M
22M
2026-03
Intuitive Surgical
USD 1.85B
68.6M
2026-03
IQVIA Holdings
USD 3.64B
112M
2026-03
Kangmei Pharma
CNY 2.61B
176.42M
2025-09
Knight Therapeutics
CAD 125.76M
7.63M
2025-12
Laboratorios Farma
EUR 107.59M
341K
2023-12
Laboratory Of America
USD 695.7M
145.1M
2026-03
Malin Corporation
EUR 700K
200K
2024-12
Medical Developments International
AUD 4.31M
2.18M
2025-12
Mesa Laboratories
USD 5.25M
163K
2025-12
Mettler Toledo International
USD 228.72M
37.91M
2026-03
Myriad Genetics
USD 32.6M
2.6M
2026-03
Neuren Pharmaceuticals
AUD 2.4M
4.26M
2025-12
OraSure Technologies
USD 10.63M
4.11M
2026-03
Organigram Holdings
CAD 71.08M
18.17M
2025-12
Ovoca Bio
EUR 186K
23K
2025-06
Pacific Biosciences Of California
USD 13.61M
7.16M
2026-03
Pharma Mar
EUR 43.83M
10.51M
2026-03
Qiagen NV
USD 72.66M
2.11M
2025-12
Quest Diagnostics
USD 1.5B
100M
2026-03
Quidel
USD 243.5M
35.9M
2026-03
Repligen
USD 34.66M
4.65M
2026-03
Revvity
USD 169.68M
15.78M
2026-03
Sartorius
EUR 345.3M
2.2M
2026-03
Sino Biopharmaceutical
CNY 2.82B
1.32B
2025-06
Thermo Fisher Scientific
USD 3.34B
278M
2026-03
Tilray
USD 114.5M
3.69M
2025-09
Waters
USD 103.78M
11.95M
2025-12
Zealand Pharma A/S
346.6M
102.71M
2025-12
Zz Pientze Pharmaceu
CNY 457.05M
59.09M
2026-03
×